CCL24 and metabolic syndrome: 3.3. Patients with Metabolic Syndrome Present a Higher Percentage of Circulating Eosinophils, Increased Number of Eosinophil-Platelet Aggregates, Enhanced Eosinophil Activation and Decreased Eotaxin-2/CCL24 Plasma Levels